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THE EXPERT REPORT
The structure of the expert report and the 
role of the expert witness are beyond the 
scope of this article. However, certain points 
are relevant when considering a claimant’s 
functional symptoms. In the history section, 
it is useful to describe a typical day and the 
range of activities undertaken on both ‘good’ 
and ‘bad’ days; this is important in interpreta-
tion of video surveillance. It helps to include a 
brief vignette of the claimant’s life, including 
any childhood adversity, if relevant—they 
may be more at risk of developing functional 
neurological disorder (FND), for example.1 
It is worth asking the claimant what they feel 
about the accident; if they believe there is 
permanent damage done, they are less likely 
to improve2 and if they harbour grievance 
towards the ‘perpetrator’, they are more 
likely to develop post- traumatic symptoms.3 4
Reliability of the claimant
In legal claims, and in clinical experience, 
claimants/patients with FND, and indeed with 
any neurological condition, may have a degree 
of volitional symptom control. This may be 
produced in order to gain relief from respon-
sibilities, for example, or a more subcon-
scious exaggeration to convince others of the 
patient’s/claimant’s suffering. At the other 
end of the spectrum is factitious disorder, 
a psychiatric condition, where patients will-
fully fabricate symptoms; and malingering, 
whereby symptoms are consciously fabricated 
for (usually material) gain. Given that, in FND, 
it will superficially appear the claimant’s symp-
toms and signs are under voluntary control, 
it is not possible to be sure if that claimant is 
fabricating or not. However, there may be 
suggestions that the claimant is an unreliable 
witness; for example, prominent mismatch 
between reported and actual function 
(observed by covert surveillance, for example), 
markedly different histories given to different 
professionals (although physical examination 
findings may vary), or a microbiology report 
suggesting a wound may have been tampered 
with. Ultimately, reliability of a claimant is for 
the court, not the expert, to decide.
Causation
FND is commonly triggered by, often minor, 
accidents and injuries. However, claimants 
who develop functional symptoms post- 
trauma may be predisposed to developing 
such symptoms anyway, and the effect of the 
accident needs to be addressed. It can be 
helpful to construct a table of general prac-
titioner visits before and after the accident; 
if they are roughly the same, with similar 
reports, then the accident may not be respon-
sible for ongoing symptoms. If a symptom 
does seem to be temporally related to the 
accident, consideration should be given to 
how severe and salient the accident was, 
and thus how plausible it was for triggering 
current symptoms. It must be borne in mind 
that many factors give rise to such symptoms, 
and in predisposed individuals, such symp-
toms may have occurred spontaneously—it 
can be helpful to put a figure on this likeli-
hood. It is also worth considering that many 
of these (painful) conditions overlap, and 
vulnerability to one often increases vulnera-
bility for another.5
FUNCTIONAL NEUROLOGICAL DISORDER
Synonyms of FND include psychosomatic, 
dissociative, nonorganic, conversion disorder, 
psychogenic. FND can comprise, for example, 
nonepileptic attacks, movement disorders 
and motor/sensory loss. FND is pertinent to 
medicolegal practise because it is common, 
can be confused with malingering, is often 
‘overlaid’ onto other disorders and often 
occurs after physical insults. Functional disor-
ders can occur in all medical specialties and 
include chronic fatigue, fibromyalgia, irri-
table bladder, irritable bowel and noncardiac 
chest pain.
FND is defined in DSM 5:
A. The patient has ≥1 symptoms of altered 
voluntary motor or sensory function.
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B. Clinical findings provide evidence of incompatibility 
between the symptom and recognised neurological or 
medical conditions.
C. The symptom or deficit is not better explained by an-
other medical or mental disorder.
D. The symptom or deficit causes clinically significant 
distress or impairment in social, occupational or oth-
er important areas of functioning or warrants medical 
evaluation.
Note that (in contrast to old definitions, and with the 
recognition that FND can occur in patients with normal 
mental health) there is no requirement to demonstrate a 
psychological trigger.
Patients with FND have neurological symptoms, but 
with no structural correlate. The deficit appears voluntary 
but is produced subconsciously.6 7 This is distinct from 
factitious disorder or malingering, whereby symptoms 
are consciously feigned. FND is thought to arise from 
increased attention to (a ‘rogue representation of’) the 
body,7 8 abnormal predictions about the body (informed 
by expectations from society/media/prior beliefs and so 
on) and altered agency (the brain misperceives internal 
sensations as external symptoms). This model explains 
why FND is often triggered by physical injury9—because 
the body ‘feels different’, especially in circumstances of 
heightened vigilance and salience (like an accident). 
Those with chronic stress, childhood adversity and 
certain personality factors may be more prone to devel-
oping FND1 10 (although they can occur in people with no 
prior adversity or personality factors). This model of FND 
also explains the persistence of, say, functional cogni-
tive complaints—the brain ‘expects’ to have symptoms 
that reflect ‘brain damage’. In the case of, say, complex 
regional pain syndrome (CRPS), the patient/claimant 
can ‘see evidence’ of an ongoing physical process, and it 
can be difficult for them to understand the brain’s role 
in the development of this disorder. It can also help to 
explain trends in litigation and post- traumatic syndromes, 
for example, whiplash, repetitive strain injury, ‘railway 
spine’. Thus, society ‘suggests’ a certain outcome from a 
particular injury, which is incorporated into the collective 
lay belief system and the brain ‘predicts’ such an outcome 
at an individual level.
The diagnosis of FND is made by detection of specific 
signs on examination11 (see criterion B). Thus, it is not 
a diagnosis of exclusion, as is often thought. Most signs 
are based on distraction (eg, the patient’s examina-
tion normalises when their brain is not focusing on the 
symptom) or lay beliefs about illness (eg, dragging of the 
foot of a weak leg). That signs improve on distraction, or 
when the claimant thinks they are not being observed, 
should not, therefore, be taken as evidence that they are 
feigning. FND is very common,12 and the misdiagnosis 
rate is very low. A study published in 196513 that reported 
a high misdiagnosis rate has been ‘revisited’14 and the 
methods and interpretation called into question15; the 
low misdiagnosis rate has been supported by subsequent 
studies.16
It is not possible to know for sure, in an individual 
person, whether their symptoms and signs are feigned or 
are functional (ie, with little or no conscious awareness 
that the signs are produced internally), aside from, for 
example, video surveillance evidence of a marked discrep-
ancy in reported and actual function. Symptoms can be 
feigned in the context of factitious disorder or malin-
gering. Factitious disorder is a mental health condition17 
and involves feigning symptoms for personal gain. There 
may be features that are more likely to occur in patients 
with factitious disorder that help distinguish from patients 
with FND.18 Malingering is the feigning of symptoms for a 
specific purpose, that is, material gain (like litigation) or 
relief from responsibilities. It should be emphasised again 
that if a claimant has functional symptoms or signs, this is 
not evidence of feigning.
Patients can have an enduring tendency to suffer func-
tional disorders and develop several/ sequential (not 
only neurological) symptoms such as fibromyalgia and 
irritable bowel syndrome; a condition defined in DSM5 
as persistent (if >6 months’ duration) somatic symptom 
disorder (see online supplemental file 1). It is important 
to recognise this because symptoms may appear to 
be related to an accident, but actually they may have 
occurred anyway.
Treatment for FND includes:
1. Understanding: a good consultation can be thera-
peutic19; website resources can be useful (eg, www. 
neurosymptoms. org, www. headinjurysymptoms. org), 
as can patient groups (FND Hope/FND Action/FND 
Dimensions/FND Friends).
2. Neurophysiotherapy20 using techniques that reduce 
focus on the abnormal body part.
3. Cognitive therapies and/or psychiatric: a psychology 
or psychiatric opinion may need to be sought. Neuro-
psychology is often helpful in cases of persistent cog-
nitive deficits; however, patients with FND can score 
very poorly on cognitive testing and this should not be 
mistaken for having a dementing illness or persistent 
‘brain damage’.
4. Reducing maintaining factors, which are typically low 
mood, poor sleep, maladaptive illness beliefs, side ef-
fects of medication (especially opiates), comorbidities 
such as migraine and other pain syndromes, and ad-
verse social circumstances, which may include litiga-
tion. Such factors are very common after accidents and 
injuries but may also predate the index accident.
A systematic review of prognosis in FND showed that 
the range of prognosis is very wide (10%–90%), with a 
mean of 39% being the same or worse at a mean follow- up 
of 7.4 years.21 Complete remission rate is estimated at 
20% (for functional motor disorders).22 It is very diffi-
cult to estimate the prognosis for an individual claimant, 
and one must consider premorbid factors, ‘maintaining’ 
factors (some of which can be ameliorated) and duration 
of symptoms.
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MILD TRAUMATIC BRAIN INJURY
There are several definitions of mild traumatic brain 
injury (mTBI).23 24 Unfortunately, some symptoms within 
some classifications are somewhat vague—‘daze’, for 
example. Dissociation (especially derealisation—the 
sense of feeling detached from one’s surrounding,25), 
caused by the stress and anxiety of the accident, may be 
one explanation for ‘loss of consciousness’ (and amnesia, 
confusion, ‘dizziness’, ‘daze’ and even seizures). It is, 
therefore, important to record contemporaneous objec-
tive findings (from paramedic and hospital records), 
rather than relying solely on the claimant’s retrospective 
recall. In many ways, whether a claimant fulfils criteria for 
mTBI or not is not particularly relevant; persistent symp-
toms are likely to be functional, whether there has been 
an insult directly to the head or not.
POSTCONCUSSION SYNDROME
This term describes a constellation of symptoms that 
can occur after ‘concussion’ (usually taken to mean 
mTBI), such as poor memory, pain, headache, dizziness, 
fatigue and psychiatric symptoms. The terminology can 
be confusing and misleading, and some have suggested 
a change in terminology, for example, to ‘post- traumatic 
syndrome’.23 26 27 The term postconcussion syndrome 
(PCS) is unhelpful, and it is clearer to describe each 
symptom in turn and consider the pathophysiological 
basis for each.
While it is certainly possible an isolated mTBI can 
produce temporary damage to the brain,28 cognitive (and 
other) symptoms that persist beyond the expected weeks 
to months are likely to have a functional basis.29 The 
symptoms of PCS are nonspecific and also occur in non- 
head injury trauma controls,30 31 healthy volunteers32 and 
personal injury litigants without head injury.33 Many more 
examples (mental health problems, chronic pain, post- 
traumatic stress disorder, whiplash, sleep deprivation, 
intercurrent illness, substance abuse, medication side 
effects, personality disorder and even the way symptoms 
are elicited by the interviewer) are discussed by Kaufman 
and colleagues in their thoughtful review.23 Premorbid 
factors predict outcome after traumatic brain injuries,34 
and several meta- analyses have shown that mTBI itself 
does not lead to persistent deficits—see Larrabee and 
Rohling,31 Kaufman et al23 and references therein.
The ‘memory’ problems described after mTBI (part 
of the PCS) are often deficits of attention and concen-
tration, that is, working, as opposed to autobiographical, 
memory. Attention and concentration are often affected 
by anxiety, depression, fatigue, sleep deprivation, medi-
cation, pain and so on—all common after mTBI. Lower 
cognitive function and alcohol use35 may be a risk factor 
for mTBI, potentially explaining some post- accident 
deficits.36
By definition, patients with (uncomplicated) mTBI have 
normal (standard) structural imaging. However, it has 
been argued that abnormalities in diffusion tensor imaging 
(DTI) reflect axonal damage, and abnormalities in DTI 
have been described after mTBI. Changes in DTI are not 
the same as ‘diffuse axonal injury’ (DAI), a term used to 
denote pathological changes after moderate to severe TBI. 
Abnormalities in DTI found in patients post- mTBI do not, 
however, provide evidence that PCS is caused by axonal 
injury at the time of the head injury. Many studies have 
examined DTI changes well after the hyperacute phase 
of injury, which may reflect post- traumatic stress disorder, 
for example. DTI changes are not specific to TBI and have 
been found in patients with depression, borderline person-
ality disorder, ageing, opiate addiction and in healthy 
volunteers. It is difficult to predict neuropsychological 
outcome from DTI changes, and results have been incon-
sistent. If PCS was caused by axonal damage at the onset 
of head injury, it might be expected that cognition would 
improve over time, as the injuries recovered; however, in 
many patients with PCS, cognition deteriorates over time. 
This might be expected to occur in patients with untreated 
functional disorders, as opposed to direct injuries. It should 
be noted that there is no good evidence that an isolated 
mTBI causes dementia. Whatever the interpretation of DTI 
changes, the technique should neither used as a proxy for 
DAI nor to provide evidence that (micro)structural brain 
injury is responsible for PCS, and more research on this 
subject is required. The issue of DTI and PCS is discussed 
elsewhere.26 31
It is important to transmit to the claimant/patient that 
their ‘PCS’ is likely to have a functional basis, as opposed to 
being secondary to persistent ‘brain damage’; if the patient 
has a prior belief that their cognitive symptoms are due to 
irreparable brain damage, or some medical ‘syndrome’ (ie, 
PCS), they are likely to worry further, thus producing more 
cognitive symptoms and so on. It is known that such illness 
beliefs are a key predictor of outcome.2 37 38 The website 
www. headinjurysymptoms. com is an excellent resource for 
patients and their family and explains this well.
DIZZINESS
Persistent or recurrent vertigo post- trauma can occur 
due to direct damage to the vestibular apparatus, vestib-
ular migraine or through functional mechanisms. It is 
important to distinguish vertigo (a sensation of move-
ment), from other forms of dizziness, such as light head-
edness. Rarely, dizziness is due to posterior circulation 
stroke (or brain stem trauma), and bedside tests can be 
used in the emergency setting to distinguish between 
central and peripheral causes of vertigo.39
The symptoms and signs of benign paroxysmal posi-
tional vertigo (BPPV) are characteristic: vertigo after a 
brief latency, provoked by head movement and of a dura-
tion usually less than a minute, diagnosed by the presence 
of symptoms and rotatory nystagmus on provocation tests 
(side lie test or Dix- Hallpike) and cured by particle repo-
sitioning manoeuvres (Semont or Epley, respectively). 
Post- trauma, however, BPPV may involve uncommon or 
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multiple canals,40 making it more difficult to diagnose 
and treat.
Vestibular migraine is a common cause of vertigo 
and is defined by the International Headache Society 
(IHS): https:// ichd- 3. org/ appendix/ a1- migraine/ 
a1- 6- episodic- syndromes- that- may- be- associated- with- 
migraine/ a1- 6- 6- vestibular- migraine/. Episodes of vertigo 
related to vestibular migraine tend to be of a longer dura-
tion and associated with other migrainous features (such 
as nausea and photophobia). While, like BPPV, it can be 
provoked by head movement (migraine is associated with 
motion sensitivity), there are often other triggers, such as 
glare, and vivid patterns.
‘Persistent postural- perceptual dizziness’ (PPPD) (see 
online supplemental file 1)39 41 42 is essentially a failure 
of the brain’s adaptation to a vestibular insult (or dizzi-
ness from acute anxiety and so on), often in predisposed 
individuals, leading to chronic dizziness and maladaptive 
behaviours (such as avoidance, a shift in favour of visual 
or sensory inputs over vestibular and cocontraction of leg 
muscles, leading to unsteadiness). PPPD is essentially a 
type of functional disorder.
Different forms of vertigo can coexist; for example, 
PPPD can be triggered by a vestibular insult, such as BPPV 
precipitated by head injury, which then resolves, leaving 
only the PPPD, or it can be accompanied by (and trig-
gered by) vestibular migraine.
HEADACHE POST-TRAUMA
Headache post- trauma is recognised by the IHS (although 
this does not prove a direct causal link). Chronic head-
ache post- trauma is often associated with ‘PCS’ and medi-
cation overuse. Chronic migraine should be treated in 
the usual way, and simple analgesia is limited to <10 days 
a month.
RISK OF EPILEPSY POST-MTBI
Functional seizures are often precipitated by acute stress and 
trauma and may be confused with epileptic seizures, partic-
ularly post- head injury. However, there is no clear evidence 
for a risk of epilepsy post- mTBI. Several studies, including 
a large study in 199843 suggested a small increased seizure 
risk, but this cannot be taken as evidence for an increased 
risk of epilepsy post- mTBI. There are a number of reasons 
why this study (and other similar studies) does not provide 
evidence for an increased risk of epilepsy post- mTBI. First, 
non- head- injury trauma controls should be used because 
there may be factors that predispose to injury in ortho-
paedic controls, as opposed to ‘normal controls’ (such as 
depression, medication use, alcohol intake, sleep distur-
bance and so on…).35 44–47 Second, ‘seizures’ are not the 
same as ‘epilepsy’ (a tendency to recurrent seizures); antie-
pileptic medication use (for epilepsy, as opposed to mental 
health disorders or pain) may be a surrogate marker for 
epilepsy, and this figure should be recorded specifically for 
patients with mTBI. Third, ‘seizures’ are not necessarily 
epileptic seizures and may be syncope, migraine,46 or, 
indeed, functional seizures.
COMPLEX REGIONAL PAIN SYNDROME
CRPS is defined by the Budapest criteria (see online supple-
mental file 1).48 The role of psychosomatic factors, and 
overlap with functional disorders,49 in CRPS is another area 
of controversy. Such controversy often arises because there 
is an implicit suggestion that ‘psychosomatic’ or ‘functional’ 
in some way implies willful exaggeration or fabrication and 
ignores the brain’s role in ‘peripheral’ abnormalities (auto-
nomic and inflammatory changes in a limb, for example). 
Furthermore, it can also imply a psychological trigger or 
vulnerability, which is not always present in a person with 
CRPS (or, indeed, FND). Patients with FND (and other 
functional conditions), however, are not willfully exagger-
ating or fabricating their symptoms; ‘central’/top down 
mechanisms can influence ‘peripheral’ changes and vice 
versa. I have not discussed CRPS further because the case 
for phenomenological and pathophysiological overlap 
between CRPS and FND is made eloquently by Popkirov 
and colleagues,50 and potential harm from such a diagnosis 
is discussed by others.51
CONCLUSION
The constellation of symptoms that follow (minor) injury 
often has a functional basis. This should not be taken 
to mean that the symptoms are not real or fabricated. 
Conversely, it is difficult to demonstrate whether a claimant 
is willfully exaggerating their symptoms, but it is possible 
in some cases to suggest they may be an unreliable witness, 
although that is for the court to decide. Functional symp-
toms should be taken seriously and addressed directly with 
the patient/claimant/defendant—if they think their symp-
toms are due to ‘nerve/brain damage’, they are less likely 
to improve. FND is treatable, and the prognosis, although 
variable, can be good. Nestled among functional symptoms 
may also be other (also treatable) conditions, both poten-
tially related to an accident (eg, BPPV, migraine) or not 
(eg, obstructive sleep apnoea). It is important, in a medi-
colegal setting, to make a judgement as to whether such 
symptoms would likely have occurred despite the accident 
and the objective previous medical history is crucial.
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